Effects of Imiquimod 5% Cream in the Prevention of Excised Keloid Recurrence

Main Article Content

Jennifer Frias
Biomedicine Institute, University of Central Venezuela

Raquel Vargas
Biomedicine Institute, University of Central Venezuela

Erika Paez
Biomedicine Institute, University of Central Venezuela

Marina Chopite
Biomedicine Institute, University of Central Venezuela

Oscar Reyes
Biomedicine Institute, University of Central Venezuela

Natalia Soucre
Biomedicine Institute, University of Central Venezuela

Nicole Swenson
Orlando Dermatology Residency, Orlando, FL

Brian Berman
Professor Emeritus, Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL

Keywords

Keloid, recurrence, excision, imiquimod

Abstract

N/A

References

1. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG et al. International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg 2002; 110: 560–571

2. Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol. 2002 Oct;47(4 Suppl):S209-11

3. Kim K, Son D, Kim J. Radiation Therapy Following Total Keloidectomy: A Retrospective Study over 11 Years. Arch Plast Surg. 2015 Sep;42(5):588-95.

Article Sidebar

Full Article PDF
Published
Jan 2, 2018
DOI https://doi.org/10.25251/skin.2.1.4

Article Details

How to Cite
Frias, J., Vargas, R., Paez, E., Chopite, M., Reyes, O., Soucre, N., Swenson, N., & Berman, B. (2018). Effects of Imiquimod 5% Cream in the Prevention of Excised Keloid Recurrence. SKIN The Journal of Cutaneous Medicine, 2(1), 44–46. https://doi.org/10.25251/skin.2.1.4
Issue
Vol. 2 No. 1 (2018)
Section
Short Communications
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Author Biography

Brian Berman, Professor Emeritus, Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL

Professor Emeritus,
Dermatology and Cutaneous Surgery

Most read articles by the same author(s)

1 2 3 > >>